Cambridge Health Alliance, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Qual Health Res. 2020 Oct;30(12):1833-1850. doi: 10.1177/1049732320937663. Epub 2020 Jul 25.
As a part of a larger, mixed-methods research study, we conducted semi-structured interviews with 21 adults with depressive symptoms to understand the role that past health care discrimination plays in shaping help-seeking for depression treatment and receiving preferred treatment modalities. We recruited to achieve heterogeneity of racial/ethnic backgrounds and history of health care discrimination in our participant sample. Participants were Hispanic/Latino ( = 4), non-Hispanic/Latino Black ( = 8), or non-Hispanic/Latino White ( = 9). Twelve reported health care discrimination due to race/ethnicity, language, perceived social class, and/or mental health diagnosis. Health care discrimination exacerbated barriers to initiating and continuing depression treatment among patients from diverse backgrounds or with stigmatized mental health conditions. Treatment preferences emerged as fluid and shaped by shared decisions made within a trustworthy patient-provider relationship. However, patients who had experienced health care discrimination faced greater challenges to forming trusting relationships with providers and thus engaging in shared decision-making processes.
作为一项更大规模的混合方法研究的一部分,我们对 21 名有抑郁症状的成年人进行了半结构化访谈,以了解过去的医疗保健歧视在塑造他们寻求抑郁治疗和接受偏好治疗方式方面所起的作用。我们招募参与者时,力求使他们在种族/族裔背景和医疗保健歧视经历方面具有异质性。参与者中包括 4 名西班牙裔/拉丁裔( = 4)、8 名非西班牙裔/拉丁裔黑人( = 8)或 9 名非西班牙裔/拉丁裔白人( = 9)。12 人报告称因种族/族裔、语言、感知社会阶层和/或精神健康诊断而遭受医疗保健歧视。医疗保健歧视加剧了来自不同背景或有污名化精神健康状况的患者在开始和继续接受抑郁治疗方面的障碍。治疗偏好表现出流动性,并受到在值得信赖的医患关系中共同做出的决策的影响。然而,经历过医疗保健歧视的患者在与提供者建立信任关系并参与共同决策过程方面面临更大的挑战。